Publications
44
Citations
613
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1998
Typically publishes in teams of ~8 · 0% small-team papers (≤3 authors) · across 3 venues
- POS0939 CLINICAL OUTCOME MEASURES THAT ARE READY FOR PHASE III TRIALS IN SYSTEMIC SCLEROSIS
Annals of the Rheumatic Diseases · 2025
- Acquired autoimmune Bartter syndrome in a patient with primary hypothyroidism
Rheumatology International · 2021
- SAT0373 Evaluation of american college of rheumatology provisional composite response (CRISS) index in the fasscinate trial
Annals of the Rheumatic Diseases · 2017
- OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up
Annals of the Rheumatic Diseases · 2017
- Proposal for a Juvenile Systemic Sclerosis Response Index(JSScRI): Result of the Consensus Meeting in Hamburg. Germany 11th of December 2016
German Medical Science (German Research Foundation) · 2017
- Annals of the Rheumatic Diseases×4
- Rheumatology International×1
- German Medical Science (German Research Foundation)×1
- Pei‐Suen Tsou
Medicine · University of Michigan
- Carleigh Zahn
Medicine · University of Michigan
- Alain Lescoat
Medicine · University of Michigan
- John Varga
Medicine · University of Michigan
- Dinesh Khanna
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile